Equity Capital Markets
Nektar Therapeutics
02/26
Âé¶¹´«Ã½ served as bookrunner for Nektar Therapeutics on its follow-on offering
Sub-Type
Follow-On Offering
Sector
Sub-Sector
Biopharma